Skip to content
Screener

Charles River Laboratories CRL Allowance for Doubtful Accounts Receivable (Current)

Allowance for Doubtful Accounts Receivable (Current) at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$33M-14.5%
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
$0
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
$38M-19.8%
IQVIA logo
IQVIAIQV
$50M+35.1%
Schrodinger logo
SchrodingerSDGR
$265K-24.3%
Danaher logo
DanaherDHR
$121M+0.8%

Other financials

Income statement

See full
Revenue$1.0B-2.7%
Gross profit$349.0M-3.5%
Operating income$119.9M+19.7%
Net income-$1.5M-103%
EPS (diluted)-$0.03-103%

Balance sheet

See full
Cash & equivalents$240.6M+30.2%
Total debt$3.0B+8.1%
Total equity$2.8B-15.3%
Total assets$7.5B-0.4%

Cash flow

See full
Operating cash flow$179.7M-12.2%
CapEx$31.1M-11.9%
Free cash flow$148.6M-12.2%

Valuation

See full
Market cap$13.22B+80.4%
Enterprise value$16.03B+60.9%
P/S3.3×+1.5×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-6%
FCF margin9.3%-5.1pp

Returns & leverage

See full
Return on equity-7.7%
Debt / equity1.1×+0.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 9:21 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001100682-26-000118
Line itemJune 27, 2026December 27, 2025
Assets
Current assets:
Cash and cash equivalents$192,025$213,770
Trade receivables and contract assets, net of allowances for credit losses of $8,715 and $10,463, respectively711,755708,856
Inventories346,260299,103
Prepaid assets100,40996,108
Other current assets178,657129,212
Total current assets1,529,1061,447,049

Item 1. Financial Statements

FAQ

What is Charles River Laboratories's allowance for doubtful accounts receivable (current)?
Charles River Laboratories (CRL) reported allowance for doubtful accounts receivable (current) of $8.72M in Q2 2026.
How has Charles River Laboratories's allowance for doubtful accounts receivable (current) changed year-over-year?
Charles River Laboratories's allowance for doubtful accounts receivable (current) decreased by 32.1% year-over-year, from $12.84M to $8.72M.
What is the long-term trend for Charles River Laboratories's allowance for doubtful accounts receivable (current)?
Over 5 years (2020 to 2025), Charles River Laboratories's allowance for doubtful accounts receivable (current) has grown at a 9.3% compound annual growth rate (CAGR), from $6.7M to $10.46M.
What does allowance for doubtful accounts receivable (current) mean?
This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.

Ask your AI about Charles River Laboratories's allowance for doubtful accounts receivable (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude